# Capricor Therapeutics, Inc. (CAPR) stock price

URL: https://funkfolio.com/stock/CAPR

> Capricor Therapeutics, Inc. (CAPR) trades at $8.82, is worth $512.81M and scores 43/100. Valuation, financials and signals.

---

## Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics, Inc. (CAPR) is a healthcare company (biotechnology) based in the United States. The share price is $8.82, up 6.27% on the day, which values the company at $512.81M. Price as of 17 Nov 2026, 17:36 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $8.82 +6.27% today
- **Market value:** $512.81M
- **Funk Score:** 43/100
- **200-week average:** $10.85 19% below
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 17:36 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Capricor Therapeutics, Inc. in more detail

CAPR trades at -6.2× next year's expected earnings. It sits 19% below its 200-week average of $10.85.

Its Funk Score is 43 out of 100 (financial strength 4.3, profitability 3.7, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold CAPR, including Peter Kolchinsky (0.3% of the portfolio).

### Superinvestors holding CAPR

1 of the investors tracked here report a position in their latest 13F filing.

- [Peter Kolchinsky RA Capital Management](https://funkfolio.com/gurus/peter-kolchinsky) 0.32% of portfolio · $36.3M · Q2 2026

### Capricor Therapeutics, Inc. (CAPR): questions and answers

**What is CAPR's PEG ratio?**

Capricor Therapeutics, Inc.'s PEG ratio is 0.38 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Capricor Therapeutics, Inc.'s market cap?**

Capricor Therapeutics, Inc. is valued at $512.81M at a share price of $8.82.

**Is CAPR above its 200-week moving average?**

No. CAPR is 18.7% below its 200-week average of $10.85. Long-term investors watch that line because strong companies rarely trade below it for long.

**Does CAPR pay a dividend?**

Capricor Therapeutics, Inc. does not currently pay a regular dividend.

**Which famous investors own CAPR?**

In their latest quarterly filings, Peter Kolchinsky (0.3% of the portfolio) hold CAPR. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Capricor Therapeutics, Inc. (CAPR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/CAPR

Underlying data: Yahoo Finance; company filings with the SEC.
